Investment Firm
Overview
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.
Mar 11, 2021
Convertible Note
Highlights
Location
Social
Investor Lead
N/A
Participant Investors
2
Investor Name |
---|
Primer Capital |
Tech Coast Angels |
MatriSys Bioscience raised $3000000 on 2021-03-11 in Convertible Note
MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.
Company Funding History
4
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Oct 08, 2018 | Seed Round - MatriSys Bioscience | 2 | - | undefined |
Oct 01, 2019 | Venture Round - MatriSys Bioscience | 2 | - | undefined |
Mar 11, 2021 | Convertible Note - MatriSys Bioscience | 2 | - | 3.0M |
Jan 05, 2017 | Convertible Note - MatriSys Bioscience | 1 | - | 1.5M |
Recent Activity
There is no recent news or activity for this profile.